Tobramycin sulfate injection
Products billed under this code include Tobramycin, Tobramycin Sulfate.
Payment limit per 80 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Tobramycin, Tobramycin Sulfate.
Payment limit per 80 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Tobramycin | Xiromed, LLC | 70700-0173-22 | 15 | $35.175 |
| Tobramycin Sulfate | Pfizer Inc | 00409-3578-01 | 25 | $58.625 |
| Tobramycin Sulfate | Baxter Healthcare Corporation | 36000-0242-01 | 15 | $35.175 |
| Tobramycin Sulfate | Baxter Healthcare Corporation | 36000-0244-25 | 25 | $58.625 |
| Tobramycin Sulfate | XGen Pharmaceuticals DJB, Inc. | 39822-0412-01 | 15 | $35.175 |
| Tobramycin Sulfate | XGen Pharmaceuticals DJB, Inc. | 39822-0412-06 | 90 | $211.05 |
| Tobramycin Sulfate | Eugia US LLC | 55150-0470-06 | 90 | $211.05 |
| Tobramycin Sulfate | FreseniUS Kabi USA, LLC | 63323-0303-51 | 90 | $211.05 |
| Tobramycin Sulfate | FreseniUS Kabi USA, LLC | 63323-0303-55 | 90 | $211.05 |
| Tobramycin Sulfate | FreseniUS Kabi USA, LLC | 63323-0305-02 | 7 | $16.415 |
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Tobramycin Sulfate | FreseniUS Kabi USA, LLC | 63323-0306-02 | 25 | $58.625 |
| Tobramycin Sulfate | FreseniUS Kabi USA, LLC | 63323-0306-30 | 150 | $351.75 |
| Tobramycin Sulfate | Mylan Institutional LLC | 67457-0428-30 | 150 | $351.75 |
| Tobramycin Sulfate | Mylan Institutional LLC | 67457-0473-22 | 25 | $58.625 |
| Tobramycin Sulfate | Slate Run Pharmaceuticals | 70436-0110-56 | 90 | $211.05 |
| Tobramycin Sulfate | Slate Run Pharmaceuticals | 70436-0110-80 | 15 | $35.175 |
| Tobramycin Sulfate | Xiromed, LLC | 70700-0173-86 | 90 | $211.05 |
| Tobramycin Sulfate | Fosun Pharma USA Inc. | 72266-0163-06 | 90 | $211.05 |
| Tobramycin Sulfate | Northstar RxLLC | 72603-0160-06 | 90 | $211.05 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $2.345 | +$0.159 | 80 MG | Tobramycin sulfate injection | v1, posted September 17, 2026 |
| 3Q26 | $2.186 | +$0.167 | 80 MG | Tobramycin sulfate injection | v1, posted September 15, 2026 |
| 2Q26 | $2.019 | −$0.052 | 80 MG | Tobramycin sulfate injection | v1, posted September 15, 2026 |
| 1Q26 | $2.071 | −$0.302 | 80 MG | Tobramycin sulfate injection | v1, posted September 15, 2026 |
| 4Q25 | $2.373 | −$0.087 | 80 MG | Tobramycin sulfate injection | v1, posted September 8, 2026 |
| 3Q25 | $2.46 | +$0.865 | 80 MG | Tobramycin sulfate injection | v1, posted March 10, 2026 |
| 2Q25 | $1.595 | −$0.371 | 80 MG | Tobramycin sulfate injection | v1, posted March 10, 2026 |
| 1Q25 | $1.966 | −$0.304 | 80 MG | Tobramycin sulfate injection | v1, posted December 19, 2025 |
| 4Q24 | $2.27 | −$0.118 | 80 MG | Tobramycin sulfate injection | v1, posted June 11, 2025 |
| 3Q24 | $2.388 | −$0.165 | 80 MG | Tobramycin sulfate injection | v1, posted June 11, 2025 |
| 2Q24 | $2.553 | −$0.111 | 80 MG | Tobramycin sulfate injection | v1, posted March 11, 2025 |
| 1Q24 | $2.664 | +$0.013 | 80 MG | Tobramycin sulfate injection | v1, posted December 19, 2024 |
| 4Q23 | $2.651 | −$0.001 | 80 MG | Tobramycin sulfate injection | v1, posted October 10, 2024 |
| 3Q23 | $2.652 | +$0.317 | 80 MG | Tobramycin sulfate injection | v1, posted June 5, 2024 |
| 2Q23 | $2.335 | −$0.382 | 80 MG | Tobramycin sulfate injection | v1, posted February 23, 2024 |
| 1Q23 | $2.717 | +$0.116 | 80 MG | Tobramycin sulfate injection | v1, posted December 6, 2023 |
| 4Q22 | $2.601 | +$0.364 | 80 MG | Tobramycin sulfate injection | v1, posted June 22, 2023 |
| 3Q22 | $2.237 | +$0.047 | 80 MG | Tobramycin sulfate injection | v1, posted June 9, 2023 |
| 2Q22 | $2.19 | −$1.928 | 80 MG | Tobramycin sulfate injection | v1, posted December 14, 2022 |
| 1Q22 | $4.118 | +$0.277 | 80 MG | Tobramycin sulfate injection | v1, posted June 8, 2022 |
| 4Q21 | $3.841 | −$0.212 | 80 MG | Tobramycin sulfate injection | v1, posted June 2, 2022 |
| 3Q21 | $4.053 | −$0.889 | 80 MG | Tobramycin sulfate injection | v1, posted June 2, 2022 |
| 2Q21 | $4.942 | +$0.345 | 80 MG | Tobramycin sulfate injection | v1, posted March 1, 2022 |
| 1Q21 | $4.597 | – | 80 MG | Tobramycin sulfate injection | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.